Holen Sie sich die Stockscreener-App
77.79
0.76%
0.59
Handel nachbörslich:
77.79
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ALC?
Forum
Prognose
Dividendenhistorie
Schlusskurs vom Vortag:
$77.20
Offen:
$77.53
24-Stunden-Volumen:
1.67M
Relative Volume:
0.90
Marktkapitalisierung:
$38.17B
Einnahmen:
$10.03B
Nettoeinkommen (Verlust:
$1.07B
KGV:
35.85
EPS:
2.17
Netto-Cashflow:
$1.39B
1W Leistung:
-2.37%
1M Leistung:
-11.73%
6M Leistung:
-14.43%
1J Leistung:
-19.51%
1-Tages-Spanne:
$77.00
$77.93
1-Wochen-Bereich:
$77.00
$79.04
52-Wochen-Spanne:
$77.00
$100.71
Alcon Inc Stock (ALC) Company Profile
Vergleichen Sie ALC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ALC
Alcon Inc
|
77.79 | 38.17B | 10.03B | 1.07B | 1.39B | 2.17 |
|
ISRG
Intuitive Surgical Inc
|
435.83 | 155.46B | 9.15B | 2.63B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
188.37 | 53.76B | 21.39B | 1.61B | 2.55B | 5.56 |
|
RMD
Resmed Inc
|
273.29 | 39.78B | 5.15B | 1.40B | 1.65B | 9.51 |
|
WST
West Pharmaceutical Services Inc
|
254.98 | 18.45B | 2.96B | 487.70M | 344.00M | 6.68 |
Alcon Inc Stock (ALC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-21 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2025-05-20 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2025-05-14 | Bestätigt | BTIG Research | Buy |
| 2025-03-28 | Bestätigt | Needham | Buy |
| 2025-03-25 | Hochstufung | BofA Securities | Neutral → Buy |
| 2025-01-24 | Bestätigt | Needham | Buy |
| 2025-01-10 | Hochstufung | Redburn Atlantic | Neutral → Buy |
| 2024-12-17 | Bestätigt | Needham | Buy |
| 2024-11-12 | Bestätigt | Needham | Buy |
| 2024-10-10 | Hochstufung | Redburn Atlantic | Sell → Neutral |
| 2024-09-10 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-07-15 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2024-05-15 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2024-04-10 | Eingeleitet | Goldman | Buy |
| 2024-03-14 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2024-02-06 | Fortgesetzt | KeyBanc Capital Markets | Overweight |
| 2024-01-23 | Eingeleitet | Bernstein | Outperform |
| 2023-12-18 | Herabstufung | Redburn Atlantic | Neutral → Sell |
| 2023-12-12 | Eingeleitet | Stifel | Buy |
| 2023-12-04 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2023-08-17 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2023-05-30 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2023-05-10 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2023-03-01 | Hochstufung | Societe Generale | Sell → Hold |
| 2022-12-22 | Eingeleitet | Mizuho | Buy |
| 2022-11-17 | Herabstufung | Societe Generale | Hold → Sell |
| 2022-08-11 | Herabstufung | Societe Generale | Buy → Hold |
| 2022-05-13 | Fortgesetzt | Credit Suisse | Outperform |
| 2022-05-12 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2022-04-08 | Eingeleitet | Needham | Buy |
| 2022-03-11 | Eingeleitet | BofA Securities | Buy |
| 2022-01-18 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2022-01-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-10-01 | Eingeleitet | Oppenheimer | Perform |
| 2021-07-14 | Eingeleitet | Deutsche Bank | Buy |
| 2021-05-06 | Hochstufung | Citigroup | Sell → Neutral |
| 2021-03-22 | Hochstufung | BTIG Research | Neutral → Buy |
| 2020-11-12 | Herabstufung | Guggenheim | Buy → Neutral |
| 2020-07-06 | Herabstufung | Citigroup | Neutral → Sell |
| 2020-07-06 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2020-06-16 | Hochstufung | Guggenheim | Neutral → Buy |
| 2020-04-08 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-03-26 | Hochstufung | Argus | Hold → Buy |
| 2020-03-24 | Hochstufung | Societe Generale | Sell → Hold |
| 2020-03-13 | Hochstufung | UBS | Neutral → Buy |
| 2020-03-05 | Eingeleitet | Citigroup | Neutral |
| 2020-02-26 | Hochstufung | Berenberg | Hold → Buy |
| 2020-01-08 | Eingeleitet | Argus | Hold |
| 2019-10-29 | Eingeleitet | Stephens | Equal-Weight |
| 2019-08-21 | Bestätigt | BofA/Merrill | Neutral |
| 2019-06-24 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2019-06-14 | Eingeleitet | BTIG Research | Neutral |
| 2019-05-10 | Eingeleitet | Robert W. Baird | Outperform |
| 2019-05-02 | Eingeleitet | Credit Suisse | Outperform |
Alle ansehen
Alcon Inc Aktie (ALC) Neueste Nachrichten
Alcon's UNITY VCS Shows Superior Efficiency in Studies, Stock Up - Nasdaq
Aug Retail: Should I hold or sell Tectonic Therapeutic Inc. nowIPO Watch & AI Enhanced Market Trend Forecasts - خودرو بانک
Alcon to Buy Staar for $1.5 Billion in Vision Surgery Expansion - MSN
Alcon AG stock hits 52-week low at $77.34 amid challenging year By Investing.com - Investing.com South Africa
Alcon AG stock hits 52-week low at $77.34 amid challenging year - Investing.com Australia
Growth Value: What is Alcon Inc.’s book value per share2025 Year in Review & High Accuracy Investment Signals - خودرو بانک
Gains Report: What is Bakkt Holdings Inc Equity Warrants 5 year growth outlook2025 Top Gainers & Free High Accuracy Swing Entry Alerts - خودرو بانک
Staar Surgical issues letter to stockholders regarding Alcon merger - Yahoo Finance
Trading Action: Is Alcon Inc forming a breakout patternJuly 2025 Volume & Fast Moving Stock Watchlists - خودرو بانک
Alcon upgraded to neutral by Redburn, operational execution cited - MSN
RBC Capital Maintains Alcon(ALC.US) With Buy Rating, Raises Target Price to $100.73 - 富途牛牛
STAAR Surgical Announces Merger with Alcon - TipRanks
Fuchs Endothelial Corneal Dystrophy Market to Evolve Rapidly Over the Next Decade by 2034, DelveInsight Observes | ProQR Therapeutics, Kowa Pharmaceuticals, Trefoil Therapeutics, Alcon Inc., Emmecell - Barchart.com
51% Premium: Medical Device Leader Alcon to Acquire STAAR Surgical in Premium Cash Deal Worth $28 Per Share - Stock Titan
Alcon (ALC) Boosts Surgical Efficiency with Unity Vitreoretinal Cataract System - GuruFocus
Alcon Announces New Time and Motion Study Results Supporting Superior Efficiency - Business Wire
Risk Check: Whats the MACD signal for Alcon IncShare Buyback & Consistent Income Trade Ideas - خودرو بانک
Alcon (ALC) Receives a Buy from RBC Capital - The Globe and Mail
Swiss eye-care giant acquires Poulsbo medical device firm - The Business Journals
Aug Breakouts: How is Alcon Inc managing supply chain issuesWeekly Trend Report & Growth Focused Stock Reports - خودرو بانک
Alcon Sues Tesla, Musk Over AI-Generated Blade Runner 2049 Imagery - WebProNews
Aug Opening: Whats the beta of Alcon Inc stockJuly 2025 Update & High Accuracy Investment Signals - خودرو بانک
Alcon Acquires LumiThera to Boost Dry AMD Treatment Options - WebProNews
Eye care giant Alcon acquires LumiThera, a Seattle-area startup behind device that treats vision loss - GeekWire
STAAR Surgical's largest holder to vote against Alcon bid - MSN
Alcon up 4% as FDA approves Tryptyr drops for dry eye - MSN
The past year for Alcon (VTX:ALC) investors has not been profitable - Yahoo Finance
North America Vision Care Market Report 2025-2033 | EssilorLuxottica, Johnson & Johnson Vision, CooperVision, Bausch + Lomb, and Alcon Lead the 37.7 Bn Competitive Landscape - Yahoo Finance
Exclusive: Shareholder revolt threatens Alcon’s takeover of STAAR Surgical - Investing.com
New company OpZira formed following Alcon’s acquisition of LumiThera - Ophthalmology Times
Alcon AG stock hits 52-week low at 77.71 USD By Investing.com - Investing.com Nigeria
Alcon announces launch of wavelight plus, fully personalized LASIK treatment, in US and Canada - Ophthalmology Times
STAA Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of STAAR Surgical Company is Fair to Shareholders - GlobeNewswire Inc.
Hyperopia Market Overview: Epidemiology, Emerging Therapies, and Key Players | Featuring Nevakar, Zeimer Ophthalmic Systems AG, Carl Zeiss Meditec AG, AbbVie, Sydnexis, ALCON Inc., Bausch Health Compa - Barchart.com
Alcon AG stock hits 52-week low at 77.71 USD - Investing.com
Alcon launches first fully personalized LASIK treatment - Eyes On Eyecare
Alcon completes acquisition of LumiThera - Modern Retina
Swing Trade: Will Alcon Inc. benefit from rate cutsWeekly Gains Report & Real-Time Stock Price Movement Reports - Lancaster City Council
Does Alcon Inc. offer margin of safetyCPI Data & Technical Entry and Exit Alerts - Lancaster City Council
Alcon announces first fully personalized LASIK treatment with wavelight plus in the US and Canada - Eyes On Eyecare
North America Intraocular Lens Market Forecast and Company - GlobeNewswire
North America Intraocular Lens Market Forecast and Company Analysis Report 2025-2033 Featuring Alcon, Bausch, Hoya, Johnson & Johnson, STAAR Surgical, Carl Zeiss, Meditec, Novartis, and USIOL - uk.finance.yahoo.com
Eye Care’s Digital Revolution: Alcon’s ESCRS 2025 Launches Signal the Future of a $90B Market - MarketsandMarkets
Dana Lynn Alcon Obituary (2025)Price, UTMitchell Funeral Home, Inc.Price - Legacy.com
OpZira launches with LumiThera diagnostic product line - Eyes On Eyecare
Short Term Trend Reversal in Alcon Inc. PossibleJuly 2025 Analyst Calls & Community Shared Stock Ideas - beatles.ru
Candlestick Reversal Detected on Alcon Inc.’s ChartTrade Signal Summary & High Conviction Buy Zone Picks - beatles.ru
Alcon Inc. Volume Confirms Breakout — Analysts Bullish2025 Bull vs Bear & Smart Swing Trading Alerts - beatles.ru
Alcon Inc. Moves Into Bullish Territory Based on MACDJuly 2025 PreEarnings & Verified Momentum Watchlists - beatles.ru
Is Alcon Inc. Forming a Bottom PatternJuly 2025 Technicals & Free Accurate Trade Setup Notifications - beatles.ru
Alcon Launches Innovations and Highlights New Study Findings At ESCRS 2025 - MarketScreener
Finanzdaten der Alcon Inc-Aktie (ALC)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.54%
0.66%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):